Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D 0002126287 XXXXXXXX LIVE Common Stock 02/03/2026 false 0001828185 91864C107 Barinthus Biotherapeutics plc. 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874 Robert Giffen Collins 8138178035 1901 Ulmerton Road, Suite 400 Clearwater FL 33762 0002126287 N International Generosity Foundation Trust OO N FL 2734189.00 0.00 2734189.00 0.00 2734189.00 N 6.7 CO Common Stock Barinthus Biotherapeutics plc. 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874 International Generosity Foundation Trust 1901 Ulmerton Road, Suite 400, Clearwater, Florida 33762, USA The Reporting Person is a non-profit trust organized under Section 501(c) of the Internal Revenue Code. Its affairs are managed by its trustee. The Reporting Person has not been convicted in any criminal proceeding during the last five years. The Reporting Person has not been a party to any civil proceeding of a judicial or administrative body of competent jurisdiction during the last five years resulting in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws. United States of America The securities reported herein were acquired by the Reporting Person through a combination of purchases and transfers. A portion of the securities was acquired using the working capital of the Reporting Person. The Reporting Person is a non-profit trust generally funded through donations, including donor-advised funds. The remaining securities were acquired through transfers or contributions to the Reporting Person and were not acquired through the use of funds. The Reporting Person acquired the securities for investment purposes and in connection with its charitable activities. The Reporting Person may, from time to time, sell or otherwise dispose of some or all of the securities, including to support its charitable purposes, or acquire additional securities, depending on market conditions and other factors. Except as set forth above, the Reporting Person has no present plans or proposals that relate to or would result in any of the actions described in Items 4(a) through (j) of Schedule 13D. Aggregate Number of Shares Owned: 2,734,189 Percentage of Class of Securities Identified: 6.7 The Reporting Person has sole voting power with respect to 2,734,189 shares, shared voting power with respect to 0 shares, sole dispositive power with respect to 2,734,189 shares, and shared dispositive power with respect to 0 shares. The Reporting Person has not effected any transactions in the securities of the Issuer during the past 60 days. No other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. Not applicable The Reporting Person does not have any contracts, arrangements, understandings or relationships (legal or otherwise) with respect to any securities of the Issuer, other than as described in this Schedule 13D. None International Generosity Foundation Trust Robert Giffen Collins Robert Giffen Collins 04/13/2026